Cannabis patient advocacy 501(c)(3) nonprofit My Compassion announced today that it will be working closely with CannaTrials to advance the study of the medical benefits of cannabis.
Chicago, IL and Las Vegas, NV – Cannabis patient advocacy 501(c)(3) nonprofit My Compassion announced today that it will be working closely with CannaTrials to advance the study of the medical benefits of cannabis. My Compassion is the country’s foremost cannabis organization dedicated to patient advocacy, education and research of cannabis based therapeutics.
About CannaTrials. CannaTrials is led by Joseph Sameh. CannaTrials supports and facilitates cannabis based clinical trials in study design, implementation, study management and closeout. Management has decades of experience using tools such as predictive modeling and real time monitoring to support their success. Sameh previously developed PhoneScreen which revolutionized patient recruitment and compliance rates of clinical trials and has authored numerous articles and coauthored textbooks on clinical trials. He later sold the company (NASDAQ:AMAC). His pioneering work in patient provider communication and clinical research methods broke the mold about the way clinical trials were conducted. “I believe the time is right to conduct serious clinical research on cannabis to prove definitively whether cannabis works, which strains are best for specific health conditions, and discover curative effects, if any”, said Sameh. He continued“Traditional academic research facilities are reluctant to allow cannabis on their campus for research. We have developed methods that eliminate the liability researchers currently are faced with and look forward to change the paradigm of cannabis research.”
About My Compassion. Since its inception in 2009, My Compassion has continued to make tremendous advancements in communicating ways for the responsible use of cannabinoid therapeutics. Its extensive educational and community outreach programs have earned it a prominent position and voice among patients and healthcare professionals. My Compassion was founded by patients who have experienced the positive effects of cannabis for conditions such as Alzheimer's, cancer, epilepsy, chronic pain and PTSD.. “We cannot sit by idly after having personally witnessed the health of thousands of sick patients improve from using cannabis, while so many others are suffering and dying”, said Parikh “there are hundreds of new products derived from cannabis that have the potential of curing deadly diseases.” My Compassion is currently working with DePaul University and the University of Michigan on cannabis research projects and is sponsor of the CINV (chemotherapy induced nausea and vomiting) and cannabis dosing clinical study in Illinois. http://www.mycompassion.org/clinical_studies
To learn more about this and how you can participate, please contact:
Heidi Parikh, President
Joseph Sameh, President
P: 773 428-0404